United Kingdom - English - MHRA (Medicines & Healthcare Products Regulatory Agency)

teva uk ltd - amiloride hydrochloride - oral tablet - 5mg

United Kingdom - English - MHRA (Medicines & Healthcare Products Regulatory Agency)

wockhardt uk ltd - amiloride hydrochloride - oral tablet - 5mg

United Kingdom - English - MHRA (Medicines & Healthcare Products Regulatory Agency)

de pharmaceuticals - amiloride hydrochloride - oral tablet - 5mg

New Zealand - English - Medsafe (Medicines Safety Authority)

apotex nz ltd - amiloride hydrochloride dihydrate 5.7mg equivalent to amiloride hydrochloride 5 mg - tablet - 5 mg - active: amiloride hydrochloride dihydrate 5.7mg equivalent to amiloride hydrochloride 5 mg excipient: croscarmellose sodium iron oxide yellow lactose monohydrate magnesium stearate microcrystalline cellulose - indicated as concomitant therapy with diuretics to conserve potassium during periods of vigorous diuresis and during long-term maintenance therapy with thiazides or other more potent diuretics. apo-amiloride when used alone has mild diuretic and antihypertensive activity.

Australia - English - Department of Health (Therapeutic Goods Administration)

aspen pharmacare australia pty ltd - hydrochlorothiazide, quantity: 50 mg; amiloride hydrochloride dihydrate, quantity: 5 mg - tablet, uncoated - excipient ingredients: calcium hydrogen phosphate dihydrate; lactose monohydrate; maize starch; guar gum; sunset yellow fcf; pregelatinised maize starch; magnesium stearate - indicated in the treatment of patients with oedema of cardiac origin; hepatic cirrhosis with ascites; hypertension in whom potassium depletion might be anticipated. moduretic, with its combination of amiloride hcl and hydrochlorothiazide, minimises the possibility of the development of excessive potassium loss in patients during vigorous diuresis for prolonged periods. moduretic, with its built-in potassium sparing agent, is especially indicated in those conditions where the positive effect on potassium balance is particularly important. moduretic may be used alone, or as an adjunct to other antihypertensive drugs. since it enhances the action of these agents, the dosage of these antihypertensive drugs may need to be reduced to avoid the risk of excessive drop in blood pressure.

Malta - English - Medicines Authority

wockhardt uk limited - amiloride hydrochloride; furosemide - tablet - amiloride hydrochloride; furosemide - diuretics

Malta - English - Medicines Authority

pinewood laboratories limited ballymacarbry, clonmel, co. tipperary, ireland - amiloride hydrochloride, furosemide - tablet - amiloride hydrochloride 5.68 mg furosemide 40 mg - diuretics

United States - English - NLM (National Library of Medicine)

bryant ranch prepack - amiloride hydrochloride anhydrous (unii: 7m458q65s3) (amiloride - unii:7dzo8eb0z3) - amiloride hcl is indicated as adjunctive treatment with thiazide diuretics or other kaliureticdiuretic agents in congestive heart failure or hypertension to: - help restore normal serum potassium levels in patients who develop hypokalemia on the kaliuretic diuretic. - prevent development of hypokalemia in patients who would be exposed to particular risk if hypokalemia were to develop, e.g., digitalized patients or patients with significant cardiac arrhythmias. the use of potassium-conserving agents is often unnecessary in patients receiving diuretics for uncomplicated essential hypertension when such patients have a normal diet. amiloride hcl has little additive diuretic or antihypertensive effect when added to a thiazide diuretic. amiloride hcl should rarely be used alone. it has weak (compared with thiazides) diuretic and antihypertensive effects. used as single agents, potassium sparing diuretics, including amiloride hcl, result in an increased risk of hyperkalemia (approximately 10% with amiloride). amilo

United States - English - NLM (National Library of Medicine)

sigmapharm laboratories, llc - amiloride hydrochloride anhydrous (unii: 7m458q65s3) (amiloride - unii:7dzo8eb0z3) - amiloride hcl tablets are indicated as adjunctive treatment with thiazide diuretics or other kaliureticdiuretic agents in congestive heart failure or hypertension to:                a. help restore normal serum potassium levels in patients who develop hypokalemia on the kaliuretic diuretic                b. prevent development of hypokalemia in patients who would be exposed to particular risk if hypokalemia were to develop, e.g., digitalized patients or patients with significant cardiac arrhythmias. the use of potassium-conserving agents is often unnecessary in patients receiving diuretics for uncomplicated essential hypertension when such patients have a normal diet. amiloride hcl tablets have little additive diuretic or antihypertensive effect when added to a thiazide diuretic. amiloride hcl tablets should rarely be used alone. it has weak (compared with thiazides) diuretic and antihypertensive effects. used as single agents, potassium sparing diuretics, including amiloride hcl tablets, result in

Belgium - English - AFMPS (Agence Fédérale des Médicaments et des Produits de Santé)

teva pharma belgium sa-nv - hydrochlorothiazide 50 mg; amiloride hydrochloride 5 mg - tablet - 5 - 50 mg - hydrochlorothiazide 50 mg; amiloride hydrochloride dihydrate 5.68 mg - hydrochlorothiazide and potassium-sparing agents